Sanofi's vaccine are the most administered pediatric vaccines in the world
10 févr. 2022 05h59 HE | ReportLinker
Lyon, Feb. 10, 2022 (GLOBE NEWSWIRE) -- A new study shows that Sanofi Pasteur is the global leader in the aP-based pediatric combination vaccines market including hexavalent, pentavalent and school...
Sanofi and Translate Bio Initiate Phase 1 Clinical Trial of mRNA Influenza Vaccine
22 juin 2021 01h00 HE | Translate Bio, Inc.
-- Trial will evaluate potential of next generation of influenza vaccines with combined mRNA technology and flu vaccine development expertise -- -- Positive preclinical safety and immunogenicity data...
Translate Bio Achieves Manufacturing Milestone Related to Influenza mRNA Vaccine Program
07 juin 2021 07h30 HE | Translate Bio, Inc.
-- $50 million milestone payment to be received this month for successful manufacturing, release, and delivery of clinical drug product to support influenza mRNA vaccine clinical trial anticipated to...
Translate Bio Announces Closing of Expanded Collaboration and Licensing Agreement with Sanofi Pasteur to Develop mRNA Vaccines for All Infectious Diseases
20 juil. 2020 16h05 HE | Translate Bio, Inc.
LEXINGTON, Mass., July 20, 2020 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative...
Translate Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
07 mai 2020 16h26 HE | Translate Bio, Inc.
-- Pursuing development of mRNA vaccine against COVID-19 through expanded collaboration with Sanofi Pasteur -- -- Existing large-scale manufacturing capacity expected to help meet needs of...
Sanofi Pasteur and Translate Bio to Collaborate to Develop a Novel mRNA Vaccine Candidate Against COVID-19
27 mars 2020 02h00 HE | Translate Bio, Inc.
The two companies will jointly investigate multiple candidates with the goal of advancing an efficacious and safe SARS-CoV-2 vaccine into clinical development PARIS and LEXINGTON, Mass., March 27,...
AbCellera Announces
AbCellera Announces an Antibody Discovery Program in Influenza Vaccine Research
06 juin 2017 09h00 HE | AbCellera
VANCOUVER, British Columbia, June 06, 2017 (GLOBE NEWSWIRE) -- AbCellera has entered into a collaborative research effort with Sanofi Pasteur, a global leader in the development and sale of vaccines...
The INTANZA(R) Experience: Canada's Very Own Home Heist Team Reunites to Bring You Flu Prevention-The Designer Way!
14 oct. 2011 11h12 HE | Sanofi Pasteur
TORONTO, ONTARIO--(Marketwire - Oct. 14, 2011) - Editors Note: There are a photo and a video associated with this press release. Yesterday, at Toronto's prestigious...